DYN logo

Dyne Therapeutics, Inc. (DYN)

Profile

Full Name

Dyne Therapeutics, Inc.

Ticker

NASDAQ: DYN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 17, 2020

Indexes

Not included

Website

http://www.dyne-tx.com

Employees

192

Key Details

Price

$9.95(+7.68%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.37(+14.68% YoY)

PE ratio

-

Next earnings date

Aug 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.95
    DYN price is $9.95

    30-Day Relative Volume

    0.91
    DYN 30-day relative volume is 0.91

    Price Performance

    Price Most recent change

    +7.68%
    DYN price was up +7.68% on Jul 25, 2025

    Price YTD change

    -57.77%
    DYN price is down -57.77% since January 1st

    Price 1-year change

    -76.7%
    DYN price is down -76.7% year-on-year

    Price 3-year change

    -6.04%
    DYN price is down -6.04% over the past 3 years

    Price Range

    Price All-time high

    $47.45
    DYN price is currently -79.03% below its historical high of $47.45

    Price 3-year low

    $6.36
    DYN price is currently +56.45% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.13B
    DYN market capitalization is $1.13 billion

    Market cap 3-year change

    +106.43%
    DYN market capitalization is up +106.43% over the past 3 years

    Market cap All-time high

    $4.74B
    DYN market capitalization is currently -76.14% below its historical high of $4.74 billion

    Market cap sector rank

    76.09%
    DYN market capitalization is higher than 76.09% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +13.53%
    DYN shares outstanding is up +13.53% year-on-year

    Shares Outstanding 3-Year Change

    +119.71%
    DYN shares outstanding is up +119.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.70
    DYN beta is 1.70

    200-day SMA

    $17.29
    DYN price is currently -42.46% below its 200-day simple moving average

    50-day SMA

    $11.01
    DYN price is currently -9.59% below its 50-day simple moving average

    RSI

    52.19
    DYN 14-day relative strength index is 52.19

    Volume

    0.91
    DYN 30-day relative volume is 0.91

    ATR

    $0.72
    DYN average true range is $0.72

    10-day Historical Volatility

    88.66%
    DYN 10-day historical volatility is 88.66%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    DYN annual revenue value is unknown

    Revenue Analysts estimate

    -
    DYN annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    DYN annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    DYN annual revenue is unknown

    EPS

    EPS

    -$3.37
    DYN annual earnings per share is -$3.37

    EPS Analysts estimate

    -$3.85
    DYN annual earnings per share is currently -12.38% lower than the consensus analysts' forecast

    EPS 1-year change

    +14.68%
    DYN annual earnings per share is up +14.68% year-on-year

    EPS Sector rank

    27.22%
    DYN annual earnings per share is higher than 27.22% of companies in Healthcare sector

    Profit

    Gross profit

    -
    DYN annual gross profit value is unknown

    Gross margin

    -
    DYN annual gross profit margin value is unknown

    Operating profit

    -$343.89M
    DYN annual operating income is -$343.89 million

    Operating margin

    -
    DYN annual operating profit margin value is unknown

    Net income

    -$317.42M
    DYN annual net profit is -$317.42 million

    Net margin

    -
    DYN annual net profit margin value is unknown

    Expenses

    Total expenses

    $343.89M
    DYN annual total expenses is $343.89 million

    Operating expenses

    $343.89M
    DYN annual total operating expenses is $343.89 million

    Cost of goods sold

    -
    DYN annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $62.48M
    DYN annual SGA is $62.48 million

    Depreciation and amortization

    $1.67M
    DYN annual depreciation & amortization is $1.67 million

    Interest expense

    -
    DYN annual interest expense value is unknown

    Income tax

    -
    DYN annual income tax value is unknown

    EBIT & EBITDA

    EBIT

    -$343.89M
    DYN annual earnings before interest & taxes is -$343.89 million

    EBITDA

    -$342.21M
    DYN annual EBITDA is -$342.21 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $691.23M
    DYN annual total assets is $691.23 million

    Non current assets

    $31.95M
    DYN annual long term assets is $31.95 million

    Current assets

    $659.28M
    DYN annual total current assets is $659.28 million

    Cash and cash equivalents

    $435.45M
    DYN annual cash & cash equivalents is $435.45 million

    Accounts receivable

    -
    DYN annual accounts receivable value is unknown

    Inventory

    -
    DYN annual inventory value is unknown

    Liabilities

    Total liabilities

    $61.40M
    DYN annual total liabilities is $61.40 million

    Long term liabilities

    $19.14M
    DYN annual total long term liabilities is $19.14 million

    Current liabilities

    $42.26M
    DYN annual total current liabilities is $42.26 million

    Accounts payable

    $6.56M
    DYN annual accounts payable is $6.56 million

    Debt

    Total debt

    $23.99M
    DYN annual total debt is $23.99 million

    Total debt 1-year change

    -12.5%
    DYN annual total debt is down -12.5% year-on-year

    Long term debt

    $19.14M
    DYN annual long term debt is $19.14 million

    Short term debt

    $4.85M
    DYN annual short term debt is $4.85 million

    Equity & Capital

    Shareholders equity

    $629.84M
    DYN annual stockholders equity is $629.84 million

    Book value

    $629.84M
    DYN annual book value is $629.84 million

    Retained earnings

    -$949.93M
    DYN annual retained earnings is -$949.93 million

    Working capital

    $617.02M
    DYN annual working capital is $617.02 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$292.37M
    DYN annual cash flow from operations is -$292.37 million

    Cash from operations 1-year change

    -55.38%
    DYN annual cash flow from operations is down -55.38% year-on-year

    Cash from investing

    -$204.08M
    DYN annual cash flow from investing activities is -$204.08 million

    Cash from investing 1-year change

    -344.96%
    DYN annual cash flow from investing activities is down -344.96% year-on-year

    Cash from financing

    $809.89M
    DYN annual cash flow from financing activities is $809.89 million

    Cash from financing 1-year change

    +1390.92%
    DYN annual cash flow from financing activities is up +1390.92% year-on-year

    CAPEX

    CAPEX

    -
    DYN annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    DYN annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$294.75M
    DYN annual free cash flow is -$294.75 million

    Free cash flow 1-year change

    -56.04%
    DYN annual free cash flow is down -56.04% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    DYN annual gross profit margin value is unknown

    Operating margin

    -
    DYN annual operating profit margin value is unknown

    Net margin

    -
    DYN annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.92%
    DYN annual return on assets is -45.92%

    ROE

    -50.40%
    DYN annual return on equity is -50.40%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DYN price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DYN price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.69
    DYN price to book ratio is 1.69

    PB ratio Sector rank

    49.96%
    DYN price to book ratio is higher than 49.96% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    DYN price to sales ratio value is unknown

    PS ratio Sector rank

    -
    DYN price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $682.06M
    DYN enterprise value is $682.06 million

    Enterprise value Sector rank

    69.56%
    DYN enterprise value is higher than 69.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.73
    DYN EV/EBITDA is -1.73

    EV/EBITDA Sector rank

    42.34%
    DYN EV/EBITDA is higher than 42.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.60
    DYN annual current ratio is 15.60

    Quick ratio

    -
    DYN annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.04
    DYN annual debt to equity ratio is 0.04

    Interest coverage ratio

    -
    DYN annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    DYN piotroski f-score value is unknown

    Altman Z-Score

    -
    DYN altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Jul 15, 25 JP Morgan
    Neutral
    Jun 26, 25 Jones Trading
    Buy
    Jun 18, 25 Guggenheim
    Buy
    Jun 18, 25 Baird
    Outperform
    Jun 17, 25 Chardan Capital
    Buy
    May 9, 25 HC Wainwright & Co.
    Buy
    May 9, 25 Chardan Capital
    Buy
    Mar 21, 25 JP Morgan
    Neutral
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Mar 17, 25 Chardan Capital
    Buy

    Institutional Ownership

    Screeners with DYN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Dyne Therapeutics, Inc.?
    • Does Dyne Therapeutics, Inc. pay dividends?
    • What sector is Dyne Therapeutics, Inc. in?
    • What industry is Dyne Therapeutics, Inc. in?
    • What country is Dyne Therapeutics, Inc. based in?
    • When did Dyne Therapeutics, Inc. go public?
    • Is Dyne Therapeutics, Inc. in the S&P 500?
    • Is Dyne Therapeutics, Inc. in the NASDAQ 100?
    • Is Dyne Therapeutics, Inc. in the Dow Jones?
    • When was Dyne Therapeutics, Inc.'s last earnings report?
    • When does Dyne Therapeutics, Inc. report earnings?

    What is the ticker symbol for Dyne Therapeutics, Inc.?

    The ticker symbol for Dyne Therapeutics, Inc. is NASDAQ:DYN

    Does Dyne Therapeutics, Inc. pay dividends?

    No, Dyne Therapeutics, Inc. does not pay dividends

    What sector is Dyne Therapeutics, Inc. in?

    Dyne Therapeutics, Inc. is in the Healthcare sector

    What industry is Dyne Therapeutics, Inc. in?

    Dyne Therapeutics, Inc. is in the Biotechnology industry

    What country is Dyne Therapeutics, Inc. based in?

    Dyne Therapeutics, Inc. is headquartered in United States

    When did Dyne Therapeutics, Inc. go public?

    Dyne Therapeutics, Inc.'s initial public offering (IPO) was on September 17, 2020

    Is Dyne Therapeutics, Inc. in the S&P 500?

    No, Dyne Therapeutics, Inc. is not included in the S&P 500 index

    Is Dyne Therapeutics, Inc. in the NASDAQ 100?

    No, Dyne Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Dyne Therapeutics, Inc. in the Dow Jones?

    No, Dyne Therapeutics, Inc. is not included in the Dow Jones index

    When was Dyne Therapeutics, Inc.'s last earnings report?

    Dyne Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does Dyne Therapeutics, Inc. report earnings?

    The next expected earnings date for Dyne Therapeutics, Inc. is August 12, 2025
    On this page